Authors: Cross, DAE Culbert, AA Chalmers, KA Facci, L Skaper, SD Reith, AD

Citation: Dae. Cross et al., Selective small-molecule inhibitors of glycogen synthase kinase-3 activityprotect primary neurones from death, J NEUROCHEM, 77(1), 2001, pp. 94-102

Authors: Culbert, AA Brown, MJ Frame, S Hagen, T Cross, DAE Bax, B Reith, AD

Citation: Aa. Culbert et al., GSK-3 inhibition by adenoviral FRAT1 overexpression is neuroprotective andinduces Tau dephosphorylation and beta-catenin stabilisation without elevation of glycogen synthase activity, FEBS LETTER, 507(3), 2001, pp. 288-294

Authors: Coghlan, MP Culbert, AA Cross, DAE Corcoran, SL Yates, JW Pearce, NJ Rausch, OL Murphy, GJ Carter, PS Cox, LR Mills, D Brown, MJ Haigh, D Ward, RW Smith, DG Murray, KJ Reith, AD Holder, JC

Citation: Mp. Coghlan et al., Selective small molecule inhibitors of glycogen synthase kinase-3 modulateglycogen metabolism and gene transcription, CHEM BIOL, 7(10), 2000, pp. 793-803

Authors: Hall-Jackson, CA Cross, DAE Morrice, N Smythe, C

Citation: Ca. Hall-jackson et al., ATR is a caffeine-sensitive, DNA-activated protein kinase with a substratespecificity distinct from DNA-PK, ONCOGENE, 18(48), 1999, pp. 6707-6713